Department of Pharmacology, Institute of Bioscience, University of Sao Paulo State, Botucatu, São Paulo, Brazil.
Theriogenology. 2011 Jan 1;75(1):17-23. doi: 10.1016/j.theriogenology.2010.07.005. Epub 2010 Sep 15.
The objective was to evaluate the effects of plasma progesterone (P4) concentrations and exogenous eCG on ovulation and pregnancy rates of pubertal Nellore heifers in fixed-time artificial insemination (FTAI) protocols. In Experiment 1 (Exp. 1), on Day 0 (7 d after ovulation), heifers (n = 15) were given 2 mg of estradiol benzoate (EB) im and randomly allocated to receive: an intravaginal progesterone-releasing device containing 0.558 g of P4 (group 0.5G, n = 4); an intravaginal device containing 1 g of P4 (group 1G, n = 4); 0.558 g of P4 and PGF(2α) (PGF; 150 μg d-cloprostenol, group 0.5G/PGF, n = 4); or 1 g of P4 and PGF (group 1G/PGF, n = 3). On Day 8, PGF was given to all heifers and intravaginal devices removed; 24 h later (Day 9), all heifers were given 1 mg EB im. In Exp. 2, pubertal Nellore heifers (n = 292) were treated as in Exp. 1, with FTAI on Day 10 (30 to 36 h after EB). In Exp. 3, pubertal heifers (n = 459) received the treatments described for groups 0.5G/PGF and 1G/PGF and were also given 300 IU of eCG im (groups 0.5G/PGF/eCG and 1G/PGF/eCG) at device removal (Day 8). In Exp. 1, plasma P4 concentrations were significantly higher in heifers that received 1.0 vs 0.588 g P4, and were significantly lower in heifers that received PGF on Day 0. In Exp. 2 and 3, there were no significant differences among groups in rates of ovulation (65-77%) or pregnancy (Exp. 2: 26-33%; Exp. 3: 39-43%). In Exp. 3, diameter of the dominant ovarian follicle on Day 9 was larger in heifers given 0.558 g vs 1.0 g P4 (10.3 ± 0.2 vs 9.3 ± 0.2 mm; P < 0.01). In conclusion, lesser amounts of P4 in the intravaginal device or PGF on Day 0 decreased plasma P4 from Days 1 to 8 and increased diameter of the dominant follicle on Day 9. However, neither of these nor 300 IU of eCG on Day 8 significantly increased rates of ovulation or pregnancy.
目的是评估血浆孕酮(P4)浓度和外源性 eCG 对定时人工授精(FTAI)方案中青春期内罗尔荷斯坦小母牛排卵和妊娠率的影响。在实验 1(实验 1)中,在第 0 天(排卵后 7 天),小母牛(n=15)肌肉注射 2 毫克苯甲酸雌二醇(EB),并随机分配接受:含有 0.558 克 P4 的阴道内释放装置(组 0.5G,n=4);含有 1 克 P4 的阴道内装置(组 1G,n=4);含有 0.558 克 P4 和 PGF(2α)(PGF;150μg 地氯前列醇,组 0.5G/PGF,n=4);或含有 1 克 P4 和 PGF(组 1G/PGF,n=3)。第 8 天,所有小母牛均给予 PGF,并取出阴道内装置;24 小时后(第 9 天),所有小母牛肌肉注射 1 毫克 EB。在实验 2 中,青春期内罗尔荷斯坦小母牛(n=292)按实验 1 处理,第 10 天(EB 后 30 至 36 小时)进行 FTAI。在实验 3 中,青春期小母牛(n=459)接受了与 0.5G/PGF 和 1G/PGF 组描述的治疗,并在第 8 天(装置取出时)肌肉注射 300IU eCG(0.5G/PGF/eCG 和 1G/PGF/eCG 组)。在实验 1 中,接受 1.0 与 0.588 克 P4 的小母牛血浆 P4 浓度显著升高,而在第 0 天接受 PGF 的小母牛血浆 P4 浓度显著降低。在实验 2 和 3 中,排卵率(65-77%)或妊娠率(实验 2:26-33%;实验 3:39-43%)在各组之间无显著差异。在实验 3 中,第 9 天给予 0.558 克与 1.0 克 P4 的小母牛的优势卵泡直径较大(10.3±0.2 与 9.3±0.2mm;P<0.01)。总之,第 0 天阴道内装置中 P4 量较少或 PGF 降低了第 1 至 8 天的血浆 P4,并增加了第 9 天优势卵泡的直径。然而,这些因素以及第 8 天 300IU 的 eCG 均未显著增加排卵或妊娠率。